Access to Information Requests Completed - January 2013

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

For the month of January 2013

Request #	Summary of Requests	Status of Completed Request	Number of Pages Disclosed
A-2009-00360	All documents regarding Bengal 120 EC Herbicide, Registration number 29268.	Disclosed in part	427
A-2010-00531	Documents dated January 2007 to July 28, 2010 related to an infant formula company with the following brand name: President's Choice.	Disclosed in part	133
A-2010-01295	All documents that pertain to drug shortages in Canada. (Jan 1, 2009 to Feb 16, 2011).	Disclosed in part	936
A-2011-00256	Documents related to a payment of $80,000 to Torys LLP in trust for Fielding Chemical Technologies Inc., as published in the Public Accounts of Canada, 2009-10.	Disclosed in part	36
A-2011-00536	AERs for the product Tylenol. Report numbers: 000343747, 000343923, 000343927, 000345098, 000347147, 000352822, 000353149, 000356214, 000356216, 000356305 and 000357387.	Disclosed in part	141
A-2011-00869	Information regarding the product Seasonique, DIN 02346176 by Teva Women's Health, Inc.	Disclosed in part	836
A-2011-01254	Briefing notes and e-mails created to brief the Health Minister (and deputy minister) and the Parliamentary Secretary on the 2014 Health Accord Renewal. (Oct 1, 2011 to Dec 22, 2011).	Disclosed in part	36
A-2011-01372	List of briefing notes prepared for the Minister. (Jan 1 2011 to Jan 31, 2012).	Disclosed in part	203
A-2011-01586	Document addressed to senior management on assessments of adverse drug reaction reports from clinical trials indicating that there may be a safety issue with a drug, for the years 2009, 2010 and 2011.	All exempted	0
A-2012-00038	All documents related to requests of applicants for information and data on herbicide residue and metabolite concentrations to the safety assessment of novel feeds and maximum residue levels. (Apr 5, 2007 to Apr 4, 2012).	Disclosed in part	9
A-2012-00142	Prescribing Information for the product Colchicine by Euro-Pharm International Canada Inc.	Disclosed in part	6
A-2012-00289	Information regarding the product Hair And Nails, NPN 80027821 by Hairfax International.	Disclosed in part	70
A-2012-00363	All adverse drug reactions reported on any prescription drug and/or Over-the-Counter (OTC) product where mannitol is used either as a primary prescription drug/OTC product or used in combination with any other prescription drug/OTC product. (Jun 6, 2007 to Jun 5, 2012).	Disclosed in part	133
A-2012-00479	All documents relating to preparation for the January 2012 meeting of the Council of the Federation.	Disclosed in part	179
A-2012-00497	Copies of the final versions of the audits conducted for the following projects: CAN-ADAPTT Practice-Based Research Network project, Youth & Elders tobacco control project, Expansion of Evidence-Based Smoking Cessation Intervention in Hospitals Across Canada.	Disclosed in part	48
A-2012-00498	Information regarding the medical device Stryker EIUS knee implants by Stryker Howmedica Osteonics Corporation.	Disclosed in part	311
A-2012-00611	Report commissioned by Health Canada/First Nations and Inuit Health Branch focussed on the Eeya-Keen Healing Centre Inc.	Disclosed in part	21
A-2012-00680	All documents relating to changes in funding to palliative care in Canada. (Sep 1, 2010 to May 1, 2012).	Disclosed in part	62
A-2012-00682	All documents relating to problems with or improvements to Homecare in Canada or First Nations, Métis and Inuit. (Aug 1, 2011 to May 31, 2012).	Disclosed in part	150
A-2012-00727	Copy of report "Cost analysis: Disposition of Controlled Substances and Offence-Related Property" commissioned by Health Canada and completed in December 2011 by a Toronto firm relating to the storage and disposal of evidence and property seized from clandestine drug labs and grow-ops.	Disclosed in part	42
A-2012-00799	Information regarding the product Accutane Roche by Hoffman-La Roche Limited.	Disclosed in part	404
A-2012-00844	Documents regarding the Chronic Disease Prevention Alliance of Canada (CDPAC). (Sep 1, 2011 to Aug 22, 2012).	All disclosed	43
A-2012-00849	All Product Monographs for the product Biaxin/Biaxin BID/Biaxin XL (clarithromycin).	All disclosed	1,231
A-2012-00897	Information regarding the product Targin (oxycodone hydrochloride / naloxone hydrochloride) by Purdue Pharma.	Disclosed in part	158
A-2012-00905	All comments received in response to Health Canada's consultation on its Proposed Approach to Managing Caffeinated Energy drinks. (Oct 6, 2011 to Nov 15, 2011).	Disclosed in part	42
A-2012-00906	All drafts and sampling results from the Motorplex at Grand Bend feasibility study to assess lead sampling and analysis methodologies.	All exempted	0
A-2012-00915	Information regarding the product Gamunex.	Disclosed in part	70
A-2012-00937	Information regarding the medical device Bryan Cervical Disc System, License number 62403.	Disclosed in part	3
A-2012-00947	Information regarding the product Genestra Brands Tm Tmg, NPN 80027421.	Disclosed in part	25
A-2012-00991	AER for the product Yaz. Report number: 000437773.	Disclosed in part	2
A-2012-01077	A copy of the file system classification manual for the records office.	All disclosed	54
A-2012-01081	Copy of the communications strategy and all documents from Health Canada, (including documents provided to the minister of Health), dealing with the Facebook site Feeding My Family. (Jul 1, 2012 to Nov 6, 2012).	Disclosed in part	12
A-2012-01125	All contracts processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of October 2012.	Disclosed in part	15
A-2012-01129	Request total amount of salmosan (50% azamethiphos wettable powder) used in Canadian Fish farms in 2010 and 2011.	Disclosed in part	1
A-2012-01147	AER. Report number: 000427363.	Disclosed in part	10
A-2012-01151	AER. Report number: 000429335.	Disclosed in part	4
A-2012-01212	AERs for the product CanesOral. Report numbers: 000426090 and 000435894.	Disclosed in part	4
A-2012-01213	AERs for the product ACTOS. Report numbers: 000438306, 000434996 and 000444830.	Disclosed in part	6
A-2012-01217	AERs for the product Tecta. Report numbers: 000425458, 000426884, 000430335, 000430343, 000430903, 000432525, 000434786, 000435110, 000435369, 000438156, 000445080 and 000446194.	Disclosed in part	13
A-2012-01218	AERs for the product Alvesco. Report numbers: 000435516 and 000435773.	Disclosed in part	2
A-2012-01219	AER for the product Omnaris. Report number: 000438005.	Disclosed in part	2
A-2012-01248	Disclosure of the stakeholders who participated in the 2011 Consultation on the Proposed Improvements to the Marihuana Medical Access Program.	Disclosed in part	13
A-2012-01271	All documents relating to Health Canada assistance needed by finance employees at Justice Canada, as a result of an incident on December 11, 2008. (Dec 1, 2008 to Dec 4, 2012).	No records exist	0
A-2012-01273	All call-ups and contracts processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of November 2012.	Disclosed in part	31
A-2012-01274	Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during November 2012.	All disclosed	2
A-2012-01276	All contracts and funding agreements with the Canadian Centre for Science in the Public Interest. (Jan 1, 2010 to Dec 4, 2012).	No records exist	0
A-2012-01277	All contracts and funding agreements with the Canadian Obesity Network. (Jan 1, 2010 to Dec 4, 2012).	No records exist	0
A-2012-01278	All contracts and funding agreements with the Quebec Coalition on Weight-Related Problems (La Coalition Poids). (Jan 1, 2010 to Dec 4, 2012).	No records exist	0
A-2012-01282	All documents related to meetings between officials from Health Canada and Teva Canada Limited on March 14, 2012.	No records exist	0
A-2012-01285	Copy of the 'lessons learned' report prepared in response to the 2012 red-meat recall and operating license suspension of establishment 38 (XL Foods).	No records exist	0
A-2012-01287	All documents to or from the Health Minister or Ministers office regarding Meningitis vaccination for university students in Canada.	No records exist	0
A-2012-01288	All call-ups Documents processed in the British Columbia Vancouver, Fraser Valley area under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of July 2012 to November 2012.	Disclosed in part	289
A-2012-01289	The total number of Health Canada Employees claims (and employer paid per claim) for Injury on Duty Leave, across Canada that have resulted in employer paid leave beyond 130. (Oct 21, 1992 to Dec 6, 2012)	No records exist	0
A-2012-01298	All documents concerning the investigations regarding E.coli 0157:H7 in Canadian meat product. (Jan 1, 2012 to Dec 7, 2012).	No records exist	0
A-2012-01300	AER for the product Adalat XL. Report number: 000445699.	Disclosed in part	2
A-2012-01302	AERs for the product Avelox. Report numbers: 000445282 and 000446913.	Disclosed in part	3
A-2012-01304	AER for the product Cipro. Report number: 000441695.	Disclosed in part	1
A-2012-01305	AERs for the product Gadovist. Report numbers: 000444023 and 000446218.	Disclosed in part	2
A-2012-01306	Information regarding the product TIAZAC XC, DIN 02256738.	Disclosed in part	2
A-2012-01307	AER for the product Magnevist. Report number: 000442048.	Disclosed in part	1
A-2012-01308	AERs for the product Nexavar. Report numbers: 000440284, 000440295, 000440643, 000441710 and 000442808.	Disclosed in part	5
A-2012-01309	AERs for the product Xarelto. Report numbers: 000444184 and 000446989.	Disclosed in part	5
A-2012-01312	List of all days in which Sandra Buckler, Chief of staff to the Minister, was present for work in the office of the Minister from the time of Ms. Buckler joining Health Canada to December 3, 2012.	No records exist	0
A-2012-01314	All correspondence, including email, text messages and reports to minister, sent and received by Sandra Buckler, Chief of Staff to the Minister, from the time of Ms. Buckler joining Health Canada to December 3, 2012.	No records exist	0
A-2012-01317	AER. Report number: 000433004.	No records exist	0
A-2012-01318	Prescribing Information for the product Empracet (cetaminophen, codeine) by Glaxosmithkline.	All disclosed	6
A-2012-01321	Copies of all contracts in relating to The Rainier Women's Treatment Centre. (Dec 13, 2007 to Dec 12, 2012)	No records exist	0
A-2012-01329	AER. Report number: 000359617.	Disclosed in part	1
A-2012-01331	AER for the product Androgel. Report number: 000395898.	Disclosed in part	2
A-2012-01332	AERs for the product Mavik. Report numbers: 000387103 and 000394523.	Disclosed in part	2
A-2012-01333	AERs for the product Prevacid. Report numbers: 000389174 and 000385806.	Disclosed in part	4
A-2012-01334	AER for the product Epival. Report number: 000394314.	Disclosed in part	1
A-2012-01335	All versions, dated on or before July 10, 2012 of resumes and/or job descriptions of any current or past member Health Canada's Wind Turbine Noise and Health Study Research Design Working Group Members/Collaborators Advisors.	Disclosed in part	1,011
A-2012-01336	Dcuments concerning any Health Canada 'Collaboration and partnership with other involved federal departments and agencies, provincial representatives and international counterparts ' regarding the Policy Work Plan/Approach and Research Approach for Wind Turbine Noise.	Disclosed in part	3
A-2012-01337	All documents and discussions concerning any 'information materials related to wind turbine noise best practices, guidance on noise in environmental assessments, fact sheets etc.' referred to in the slide entitled 'Policy Work Plan/Approach' in Health Canada Policy and Research Approach for Wind Turbine Noise, A Presentation to the Science Advisory Board February 2, 2012. (Feb 2, 2012 to Dec 18, 2012).	No records exist	0
A-2012-01339	All documents of 'other Health Canada efforts' in the area of 'health impacts and exposure to wind turbine noise' referred to in Ms. Tara Bower's Email dated May 3, 2012.	No records exist	0
A-2012-01340	All documents and discussions concerning any 'problematic wind farm establishments' referred to in the slide entitled 'Policy Work Plan/Approach' in Health Canada Policy and Research Approach for Wind Turbine Noise, A Presentation to the Science Advisory Board February 2, 2012. (Feb 2, 2012 to Dec 18, 2012).	No records exist	0
A-2012-01341	Documents of the articles entitled: - A review of Research on Noise Annoyance Conducted at Health Canada's Acoustic Division' Michaud, and Keith. - Environmental Noise Assessment Methods in Canada' (inter. Noise 2010), Keith, Michaud, Bly.	No records exist	0
A-2012-01342	All documents and discussions concerning Canadian Guidelines for Wind Turbine Noise Working Group of the Federal/Provincial/Territorial Committee on Health and the Environment. (Nov 1, 2011 to Dec 18, 2012).	No records exist	0
A-2012-01358	AER. Report number: 000366432.	Disclosed in part	2
A-2012-01363	All documents pertaining to the Department's rationale/justification for not allowing its employees to have total control over whether their Simian Foamy Virus (SFV) test results are or are not placed in their Health Canada medical file.	No records exist	0
A-2012-01364	All documents that support the Director General's statement/contention that Health Canada's Rhesus monkeys have been tested for Simian Foamy Virus (SFV) and no SFV infections were found.	No records exist	0
A-2012-01365	All documents relating to the Procurement Strategy for Aboriginal Business regarding their targets (and how are they being met). (Apr 1, 2010 to Dec 18, 2012).	All disclosed	18
A-2012-01369	Information regarding the product Redline RTD, licence application file number 500592.	No records exist	0
A-2012-01370	Information regarding the product Power Pump 7, licence application file number 132190.	All disclosed	204
A-2012-01385	AER. Report number: 000378083.	Disclosed in part	2
A-2012-01387	List of briefing notes prepared for the Minister. (Nov 1, 2012 to Dec 11, 2012).	Disclosed in part	33
A-2012-01420	All documents related to Medical Marihuana Dispensaries regarding Quality Control, Product Inspections and related issues and their resolution in British Columbia and Alberta.	No records exist	0
A-2012-01422	Names of all of the Doctors who have prescribed Medical Marihuana in British Columbia and Alberta. (Jan 2, 2010 to Dec 1, 2012).	All exempted	0
A-2012-01433	List of every drug where a Special Access Program request was granted for the year 2010.	All disclosed	18
A-2012-01434	List of every drug where a Special Access Program request was granted for the year 2011.	All disclosed	24